A detailed history of Orion Portfolio Solutions, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 86,802 shares of GILD stock, worth $8.16 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
86,802
Previous 86,168 0.74%
Holding current value
$8.16 Million
Previous $5.91 Million 23.08%
% of portfolio
0.08%
Previous 0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$66.59 - $83.99 $42,218 - $53,249
634 Added 0.74%
86,802 $7.28 Million
Q2 2024

Aug 13, 2024

SELL
$63.15 - $72.88 $88,346 - $101,959
-1,399 Reduced 1.6%
86,168 $5.91 Million
Q1 2024

May 09, 2024

SELL
$71.58 - $87.29 $562,475 - $685,924
-7,858 Reduced 8.23%
87,567 $6.41 Million
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $1.2 Million - $1.36 Million
-16,332 Reduced 14.61%
95,425 $7.73 Million
Q3 2023

Nov 01, 2023

SELL
$73.94 - $80.67 $480,314 - $524,032
-6,496 Reduced 5.49%
111,757 $8.38 Million
Q2 2023

Aug 17, 2023

BUY
$76.01 - $86.7 $3.93 Million - $4.48 Million
51,730 Added 77.76%
118,253 $9.11 Million
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $1.76 Million - $2 Million
23,094 Added 53.18%
66,523 $5.13 Million
Q1 2023

Aug 30, 2023

BUY
$77.31 - $88.08 $166,293 - $189,460
2,151 Added 1.82%
120,404 $9.99 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $1.17 Million - $1.34 Million
15,161 Added 53.63%
43,429 $3.6 Million
Q4 2022

Feb 08, 2023

BUY
$62.32 - $89.47 $430,132 - $617,521
6,902 Added 32.3%
28,268 $2.43 Million
Q3 2022

Nov 09, 2022

BUY
$59.54 - $68.01 $613,797 - $701,115
10,309 Added 93.24%
21,366 $1.32 Million
Q2 2022

Jul 14, 2022

SELL
$57.72 - $65.01 $18,297 - $20,608
-317 Reduced 2.79%
11,057 $683,000
Q1 2022

May 19, 2022

SELL
$57.92 - $72.58 $191,599 - $240,094
-3,308 Reduced 22.53%
11,374 $676,000
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $104,067 - $118,118
1,604 Added 12.26%
14,682 $1.07 Million
Q3 2021

Nov 10, 2021

SELL
$67.69 - $73.03 $18,547 - $20,010
-274 Reduced 2.05%
13,078 $914,000
Q2 2021

Aug 05, 2021

BUY
$63.47 - $69.35 $444,226 - $485,380
6,999 Added 110.17%
13,352 $919,000
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $50,880 - $58,054
848 Added 15.4%
6,353 $411,000
Q4 2020

Feb 04, 2021

SELL
$56.65 - $64.55 $106,615 - $121,483
-1,882 Reduced 25.48%
5,505 $321,000
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $57,690 - $72,536
929 Added 14.39%
7,387 $467,000
Q2 2020

Aug 19, 2020

BUY
$72.34 - $84.0 $106,122 - $123,228
1,467 Added 29.39%
6,458 $497,000
Q1 2020

May 15, 2020

BUY
$62.63 - $80.22 $128,266 - $164,290
2,048 Added 69.59%
4,991 $373,000
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $181,347 - $199,476
2,943 New
2,943 $191,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.